Resolute Onyx
Payments companies reported to CMS as associated with Resolute Onyx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Resolute Onyx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Resolute Onyx
These are the largest totals companies reported as associated with Resolute Onyx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rhian Davies | York, PA | Cardiovascular Disease | $23,392.03 |
| Kathleen Kearney | Seattle, WA | Interventional Cardiology | $21,735.42 |
| Amir Kaki | Detroit, MI | Interventional Cardiology | $19,722.45 |
| Shailendra Singh | Allentown, PA | Interventional Cardiology | $15,738.74 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $14,512.50 |
| Nishant Sethi | Scranton, PA | Interventional Cardiology | $12,386.06 |
| Mahesh Anantha Narayanan | Little Rock, AR | Interventional Cardiology | $11,529.88 |
| Arshad Ali | El Paso, TX | Cardiovascular Disease | $11,210.37 |
| Christopher Manion | Buffalo, NY | Interventional Cardiology | $10,277.25 |
| Sergio Waxman | Burlington, MA | Interventional Cardiology | $9,986.37 |
Prescribed Resolute Onyx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.